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A B S T R A C T
Background: Gait impairment in Parkinson’s disease (PD) patients is characterized by the inability to
generate appropriate stride length. Treadmill training has been proposed as a therapeutic tool for PD
patients. However, it remains unknown whether treadmill training effects are different from overground
walking training. Thus, our goal was to explore the effects of two training programs, walking on a
treadmill and walking overground, in PD patients.
Methods: 22 PD patients were randomly assigned to a treadmill or overground training group. The
training program consisted of 5 weeks (3 sessions/week). Before and after the program we evaluated gait
kinematics during walking at preferred and maximal speed; Timed Up and Go (TUG); static
posturography and knee extensors strength. Gait parameters were reevaluated in the treadmill training
group one month after the cessation of the training.
Results: Preferred speed walking improved in both groups after the training program. The treadmill
training program, but not the overground, led to an improvement in the stride length at the preferred and
maximal walking speed in the PD patients. In addition, the treadmill training group showed
improvement of the TUG and static posturography tests. The improvement in gait parameters was
maintained one month after the cessation of the treadmill training.
Conclusions: This study provides evidence of a speciﬁc therapeutic effect of treadmill training on
Parkinsonian gait and balance. Walking on a treadmill may be used as an easy, effective and accessible
way to improve the stride length and balance in PD patients.
 2013 Elsevier B.V. All rights reserved.
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Gait disturbances are one of the principal and most incapaci-
tating symptoms of Parkinson’s disease (PD). PD gait is character-
ized by the inability to generate appropriate stride length [1].
Associated disturbances include a forward-ﬂexed trunk, inade-
quate ﬂexion at the ankle and knee, insufﬁcient heel strike,
reduced arm swing, postural instability, asymmetric stride times
for lower limbs and high stride-to-stride variability [2–7].
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rehabilitation and exercise interventions in PD patients. However,
due to the age-associated progressive loss of physical function it is
difﬁcult to elucidate which rehabilitation approach has a speciﬁc
impact in PD rather than a generalized beneﬁt from exercise. For
example, several studies have shown that rehabilitation in PD
patients can result in an improvement of the preferred walking
speed but does not enhance stride length [8].
In the last 10 years there has been an increased interest in
investigating treadmill training as a potential therapeutic tool for
PD patients [9–12]. Toole et al. [10] showed an improvement in the
gait and balance in PD patients after a 6-week treadmill walking
program. Enhancement in the gait rhythmicity and improvements
in the motor signs have also been reported. In addition, several
studies show that one single session with the treadmill can be
effective in improving the gait parameters in PD subjects [13–15].
One hypothesis to explain the therapeutic effect of the treadmill
suggests that the beneﬁts may be related to proprioceptive sensory
Table 1
Clinical characteristics of PD subjects. Details of Parkinson’s disease patient characteristics.
Patient number Age
(years)
Sex Height
(m)
Disease
duration
(years)
Type H&Y UPDRS
motor
Medication per day (mg)
Treadmill training patients
1 66 F 1.60 12 T 2.5 12 Levodopa/Carbidopa 200/50, Levodopa/Benserazide 550/137.5,
Rotigotine 6, Rasagiline 1, Amantadine 200
2 79 F 1.49 7 AR 3 35 Levodopa/Carbidopa 400/50, Pramipexole 0.18
3 58 M 1.76 6 M 2 23 Levodopa/Carbidopa 500/125, Rasagiline 1, Rotigotine 4
4 60 M 1.69 6 AR 2 12 Levodopa/Carbidopa 800/200, Entacapone 800, Pramipexole 3.15
5 60 M 1.68 7 M 2 13 Levodopa/Carbidopa 500/125, Ropinirole 12, Trihexyphenidyl 2
6 62 F 1.59 2 AR 3 31 Levodopa/Carbidopa 600/150, Entacapone 600, Rotigotine 6,
Pramipexole 3.15
7 68 M 1.65 1 AR 2.5 16 Levodopa/Carbidopa 150/37.5, Entacapone 600, Rasagiline 1
8 50 M 1.70 5 AR 2 19 Levodopa/Carbidopa 300/75, Rasagiline 1, Rotigotine 8
9 67 M 1.80 3 M 2 15 Levodopa/Benserazide 500/125, Rasagiline 1, Pramipexole 2.64
10 39 F 1.63 1 T 2 18 Levodopa/Carbidopa 375/93.75, Entacapone 600, Rasagiline 1
11 45 M 1.74 3 M 2 11 Levodopa/Carbidopa 225/56.25, Entacapone 600, Rasagiline 1,
Rotigotine 4
Mean 59.45 1.66 4.82 2.27 18.64
SD 11.32 0.08 3.28 0.41 7.99
Overground training patients
1 55 M 1.72 6 M 2 23 Levodopa/Carbidopa 225/56.25, Entacapone 600, Rasagiline 1,
Ropinirole 20
2 56 M 1.65 2 AR 1.5 12 Pramipexole 2.1
3 51 F 1.68 5 AR 2 36 Levodopa/Benserazide 600/150
4 46 F 1.61 6 M 2.5 23 Levodopa/Carbidopa 150/37.5, Entacapone 600, Rasagiline 1
5 46 F 1.62 1 AR 2 23 Levodopa/Carbidopa 150/37.5, Rasagiline 1, Pramipexole 3.15
6 62 M 1.73 4 AR 2 12 Levodopa/Carbidopa 150/37.5, Entacapone 600, Pramipexole 3.15
7 61 F 1.57 6 M 2 23 Levodopa/Carbidopa 500/50, Pramipexole 3.15
8 63 M 1.74 8 AR 2 21 Levodopa/Carbidopa 750/187.5, Entacapone 1000, Rasagiline 1,
Pramipexole 3.15
9 78 M 1.62 9 AR 3 38 Levodopa/Carbidopa 400/100, Levodopa/Benserazide 700/175,
Ropinirole 20
10 54 F 1.57 6 AR 2.5 25 Levodopa/Carbidopa 400/100, Entacapone 800, Rotigotine 12
11 66 M 1.67 1.5 T 1 7 Levodopa/Carbidopa 375/37.5, Rasagiline 1
Mean 58.00 1.65 4.95 2.05 22.09
SD 9.38 0.06 2.59 0.52 9.44
p value between groups 0.74 0.63 0.91 0.42 0.36
Abbreviations: AR, akinetic-rigid; T, tremor-dominant; M, mixed.
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However, it remains unknown whether the beneﬁts associated
with treadmill training are related to the treadmill itself or
whether they are simply related to the amount of walking practice
that is afforded through treadmill training [17]. Thus, the goal of
this study was to explore the effects of two training programs in PD
patients: treadmill walking and overground walking. Both
programs had the same intensity and volume of training. We
evaluated several motor tasks such as gait, balance and knee
extensors strength before and after each training program. We
hypothesized that treadmill training, but not overground walking,
would lead to motor improvements in the PD patients.
2. Methods
Twenty-two patients with PD (13 males and 9 females, mean
age 58.72  10.35) were recruited from the local community and
local Parkinson’s disease Association, under the supervision of a
neurologist and physical therapist. Nineteen patients were in a mild
state (range of H&Y from I to II) and three in a moderate state (III of
H&Y). PD patients were excluded if they had a past history of
neurological conditions other than PD, orthopedic, or visual distur-
bance that affected walking ability. Cardiopulmonary parameters
were tested using a graded exercise test (with monitoring of ECG and
blood pressure) on the treadmill. Patients that presented signs of
cardiovascular or autonomic dysfunction were excluded from the
study. A fundamental requirement for inclusion in the study was theability to walk for 10 min without stopping, walking aids or
assistance. All tests were carried out while the patients were ON
medication, corroborated by a neurologist and consistently done at
the same time of day for each patient. The level of functional disability
was determined using the Uniﬁed Parkinson’s Disease Rating Scale
(UPDRS) and the Hoehn and Yahr (H&Y) scale. The dominant
symptoms were tremor, akinetic-rigid and mixed phenotype in 3,
12 and 7 patients, respectively. No patient showed dementia as
assessed by a mini-mental state examination (MMSE > 26) and all of
the patients provided their written informed consent to participate in
this study. The local ethic committee of University of A Corun˜a
approved the experimental protocol. Details of the subjects are shown
in Table 1.
2.1. Procedure
The patients were randomly assigned to a treadmill training
group (Gtreadmill) or overground group (Goverground). All
patients were evaluated before (T0) and after the training program
(T1). In addition, gait evaluation was repeated in the Gtreadmill
group one month later (T2), since this group showed a signiﬁcant
improvement in the stride length after the training program.
During this month the patients did not change their daily activities.
The training program consisted of 5 weeks, 3 session/week of
walking on a treadmill (Gtreadmill group) or walking overground
(Gground). In the ﬁrst week, each session consisted of 4 bouts of
4 min of walking, with 3 min rest between bouts. Each week an
Table 2
Training effects on the tasks evaluated.
Item Group
Gground Gtreadmill
T0 T1 T0 T1 T2
UPDRS
Motor score 22.09  2.84 18.2  2.01 18.64  2.4 21.27  2.72
Walking at preferred speed
Speed (m/s) 1.33  0.07 1.39  0.08* 1.26  0.09 1.36  0.09* 1.37  0.11*
Cadence (steps/min) 117.98  3.52 120.69  3.54* 118.59  2.77 121.58  2.74* 123.47  2.73*
Stride length (m) 1.35  0.05 1.38  0.05 1.27  0.08 1.33  0.07* 1.33  0.08*
Walking at maximal speed
Speed (m/s) 1.78  0.1 1.76  0.07 1.63  0.14 1.69  0.12 1.71  0.13
Cadence (steps/min) 135.85  4.11 135.74  2.6 134.02  4.28 135.4  3.18 136.88  3
Stride length (m) 1.56  0.05 1.55  0.05 1.44  0.09 1.49  0.09* 1.52  0.11*
Walking on treadmill at initial preferred speed
Speed (m/s) 1.33  0.07 1.33  0.07 1.26  0.09 1.26  0.09
Cadence (steps/min) 118.8  4.34 118.8  4.7 117.6  3.62 117.6  4.34
Stride length (m) 1.36  0.05 1.35  0.07 1.29  0.03 1.28  0.07
TUG
Total time (s) 10.17  0.45 10.30  0.68 12.87  1.73 11.26  1.07*
Time to stand up (s) 1.04  0.09 1.11  0.12 1.52  0.32 1.10  0.16*
Time to walk (s) 2.20  0.08 2.13  0.11 2.53  0.3 2.44  0.21
Time to turn (s) 2.62  0.16 2.57  0.19 3.23  0.44 2.76  0.27*
Time to back (s) 2.16  0.08 2.18  0.11 2.70  0.39 2.43  0.19
Time to sit down (s) 2.14  0.12 2.31  0.18 2.89  0.4 2.53  0.29*
Posturography
Eyes open (mm2) 3356  432 2707  421 2599  313 3013  454
Eyes close (mm2) 4143  621 3210  405 3709  355 4101  436
Eyes open and cognitive task (mm2) 2514  361 2421  476 2726  253 3156  543
Eyes close and cognitive task (mm2) 3813  548 2992  455* 3050  252 3882  555*
Cognitive task with eyes open (score) 1  0.2 1  0.25 0.82  0.23 1.09  0.21
Cognitive task with eyes close (score) 1.40  0.21 1.40  0.21 0.82  0.18 1.45  0.25*
Knee extensor
Both legs (N) 1261  145 1237  124 1344  189 1332  179
Affected leg (N) 650  106 578  72 817  138 804  129
Non-affected leg (N) 649  83 573  62 863  141 841  136
T0 (evaluation before training program), T1 (evaluation after training program), and T2 (evaluation one month after training program).
* Signiﬁcant differences with T0 (p  0.05). Note that no differences were found between groups at T0.
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training sessions remained constant and was determined as the
individual preferred speed obtained for each subject during the
ﬁrst evaluation. Patients from the Gtreadmill group were asked to
walk on a treadmill (SporsArt 6300, Sports Arts Fitness) without
body weight support, wearing a safety harness to prevent falls. In
addition, all patients were asked to hold on to the handrails of the
treadmill regardless of whether they needed to or not. All patients
were able to walk on the treadmill at their overground comfortable
speed from the ﬁrst block of the ﬁrst session. The training of the
Gground group was conducted in an indoor facility 60 m long and
10 m wide. In order to control the walking speed of the Ground
patients, each patient wore an MP3 device that provided auditory
cues. Between each auditory cue the patients had to walk a
distance of 10 m. To provide feedback to the patients regarding
their speed, cones were located on the side of the walkway each
10 m. At the moment of each auditory cue, the patient had to arrive
to the cone. The pace of the auditory cues was adjusted to the
preferred speed of each patient. In a pilot study we determined that
the auditory cues did not affect any of the gait parameters in the
patients. The walking speed of each patient was monitored in each
of the training sessions in order to conﬁrm that the patient was
walking at the desired speed.
Before the initial evaluation, all the patients were familiarized
with the test for an duration of a week in order to avoid a possible
learning effect. All testing and training sessions were carried out
while the patients were ON medication.2.2. Tasks
2.2.1. Gait evaluation tests
The patients performed the following tests in the following
order: (i) walking overground for 4 min at their preferred speed;
(ii) walking overground for 10 m at maximal speed. All gait tests
were performed in the indoor facility described previously. In
addition, the patients walked for 4 min on a treadmill at their
preferred speed (the same speed that was obtained for overground
walking) before the training program (T0). Speed (m/s), cadence
(steps/min) and stride length (m) were recorded using force
sensitive switches placed in the patient’s shoe and synchronized
with photocells (BTS SMART Analyzer system) that were placed
each 30 m across the walkway.
2.2.2. Timed Up and Go (TUG)
Patients were seated on a chair, and were instructed to stand up,
walk at their own comfortable and safe walking speed for 3 m,
turn, come back, and sit down on the chair again. We recorded the
duration of the following parameters: time to stand up, time to
walk 3 m, time to turn, time to return 3 m, time to sit down, and the
total time of all the variables. These parameters were recorded
using a digital system developed in our laboratory.
2.2.3. Static posturography
The area of the center of pressure (CoP) was recorded for the
quiet stance using a stabilometric platform (Kistler 9286BA) in four
Fig. 1. Training effects on gait measures. T0 (evaluation before training program), T1 (evaluation after training program), and T2 (evaluation one month after training
program). * Signiﬁcant differences with T0 (p  0.05) in the treadmill training group. # Signiﬁcant differences with T0 (p  0.05) in the overground training group.
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and in the absence of performing a cognitive task. The subjects’ feet
were placed in parallel and spaced 10 cm apart. One 60 s trial was
recorded for each condition. During the balance tests the patients
were instructed to keep a stance position. For the dual-task
condition patients were asked to keep a stance position and to
perform the additional cognitive task. No instructions for priority
of one of the tasks were given (stand vs. cognitive task). In the
cognitive task condition the patients were required to listen to one
of the researchers reading a text and at the end report the number
of times that two different words, previously reported, were
repeated. To quantify the cognitive task we assigned 1 point for
each correct recall of a word.
2.2.4. Knee extensors strength testing
For the isometric knee extension force tests, the patients were
placed in a seated position on an isometric knee extensor machine
(Leg Extension MED, Technogym Trading S.A.) and were securely
strapped into the test chair. The chair had a long backrest, providing
full back and head support. The hip and knee were at 908 of ﬂexion (a
08 knee extension refers to a horizontal leg–thigh position). After a
warm-up we recorded two trials of maximal voluntary knee force
extensions performed with both legs simultaneously, two trials with
the right leg and two trials with left leg.
2.3. Statistic analysis
ANOVA of repeated measures was conducted with Group
(Gtreadmill and Gground) and Time (T0, and T1) as factors for thefollowing variables: speed, stride length and cadence for the gait
tasks; time to stand up, time to walk 3 m, time to turn, time to
return 3 m, time to sit down and the total time for the TUG test;
area of CoP during posturography tests; and maximal voluntary
contraction during the knee extensor strength test.
Wilcoxon test was performed in the comparison of the
cognitive task score during the posturography tests and in the
comparison of the motor section score of the UPRDS, between T0
and T1 in each group.
T tests were conducted in the comparison of the gait parameters
in the Gtreadmill group between T0 and T2.
All statistical analyses were performed using SPSS (SPSS,
Chicago, IL). A p value  0.05 was considered statistically signiﬁ-
cant.
3. Results
Both groups were homogeneous in all the variables analyzed
since there were no signiﬁcant differences between the groups at
T0 (Table 2).
The total walking time of the program was 360 min for each
patient.
The ANOVA showed a signiﬁcant effect of Time factor during the
4 min walking, for the speed (F = 19.84, p < 0.001) and cadence
(F = 17.47, p < 0.001), without a signiﬁcant group effect or
Group  Time interaction. Both speed and cadence increased
signiﬁcantly in both groups after the training program. However,
the ANOVA showed a signiﬁcant effect of Time (F = 13.92, p < 0.01)
and Group  Time interaction (F = 4.48, p < 0.05) for the stride
Fig. 2. Training effects on center of pressure (CoP) during quiet stance with eyes closed and during the cognitive task. Left ﬁgure shows the changes of the area of CoP for each
group after the training program. Right ﬁgure represents the CoP traces in two patients, before and after the treadmill training (upper graphs) or overground training (lower
graphs). T0 (evaluation before training program) and T1 (evaluation after training program). * p  0.05.
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signiﬁcantly (p < 0.05) in the treadmill group, and not in the
overground group. The stride length increased by 5.70% after the
training program, and was signiﬁcantly larger compared to the
1.71% increase that was observed in the Gground group (p < 0.047).
For the test in which patients walked 10 m at maximal speed,
we did not ﬁnd signiﬁcant differences in the cadence and speed
before and after the training programs. For the stride length the
ANOVA showed a signiﬁcant Group  Time interaction (F = 5.53,
p = 0.029). Post hoc analysis showed a signiﬁcant increase of stride
length in the treadmill group after the treadmill training program
(p = 0. 010) but no signiﬁcant differences before and after training
in the overground group. The increase in the treadmill group was of
3.46%, which was signiﬁcantly larger than in the overground group
(0.60%, p = 0.04).
The improvements in gait for both the 4 min and maximal
speed walking tests were maintained in the Gtreadmill group one
month after the end of the training program. Fig. 1 illustrates the
average gait parameters for gait at the preferred speed and gait at
the maximal speed for all the patients.
For the TUG test the ANOVA showed signiﬁcant Group  Time
interactions for the total time to complete the test (F = 5, p = 0.05),
time to stand-up (F = 5.64, p = 0.02), turn (F = 6. 45, p = 0.01) and sit
down (F = 9.99, p = 0.005). The post hoc showed a signiﬁcant
decrease (p < 0.05) in all these parameters in the treadmill group
and no signiﬁcant changes in the overground group.
The ANOVA for the static posturography parameters showed a
signiﬁcant Group  Time interaction for the area of CoP, only in the
condition with eyes closed while performing a cognitive task
(F = 4.86, p = 0.03). Post hoc analyses indicate a signiﬁcant increase
in this parameter for the treadmill group (p = 0.03) and a signiﬁcant
decrease for the overground group (p = 0.02). There was a signiﬁcant
improvement (p = 0.03) in the cognitive test score after the training
program for the treadmill group, and no signiﬁcant changes in the
overground group. Fig. 2 illustrates CoP measures and provides an
example of one subject in each group.
No signiﬁcant differences were found for the knee extensor
strength test.
4. Discussion
The main ﬁnding of the present study is that a training program
consisting of walking on a treadmill, but not overground, led to animprovement in the stride length at the preferred and maximal
walking speed in PD patients. These improvements were main-
tained one month after the cessation of the training.
The gait in Parkinson’s disease is affected mainly due to a
reduced amplitude of the stride length, while the cadence
remains unaffected [1]. In our study, both groups improved their
preferred speed after the training programs. The improvement in
the overground group was due to an increase in the cadence but
not the stride length, suggesting a generalized beneﬁt from
exercise. However, the improvement of the stride length that
was observed only in the group that trained on the treadmill
highlights a speciﬁc effect of treadmill training. In the treadmill
group, stride length improvements were seen for both preferred
and maximal speed of stride length. While the improvement of
the stride length at the preferred speed could have resulted from
an overall increase in speed, this is unlikely for the maximal gait
parameters, since only the maximal stride length increased after
the treadmill training and not the maximal speed. Thus, it seems
that the treadmill training lead to an increase in stride length and
thus to a recovery of a more normal pattern of gait overground.
Importantly, the improvement in the stride length of the patients
in the treadmill group was only observed once these patients
walked overground but not apparent while they were walking on
the treadmill. This may be due to the mild to moderate state of
the disease in the cohort of patients, since a previous study
shows that only PD patients in an advanced state (III or higher of
H&Y scale) increased the stride length when walking on the
treadmill [13].
One possible explanation for the improvement of the stride
length that was observed in the treadmill group may be due to
an improvement in the balance of the patients. This is supported
by our ﬁndings that the patients were able to stand up, turn and
sit down faster after the treadmill training. These are all
movements that require a large degree of balance. These
ﬁndings are in line with previous studies that have shown that
balance improvements were associated with treadmill training
[10,18,19]. Moreover, in our study, during the static balance test,
where patients had to perform a cognitive task with closed eyes,
only the PD patients that completed the treadmill training were
able to increase the area of CoP and improve their performance
of the cognitive task. Sway area has been shown to be reduced in
PD patients [20], thus our results suggest that the PD patients
improved their balance after the treadmill training, allowing
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cognitive task. We speculate that the improvement in balance
may allow the patients to project their center of mass forward to
a greater extent and as a result improve their gait by increasing
their stride length. In addition, the absence of change in the
strength of the knee extensor muscles in the patients, rule out a
possible peripheral muscle effect as a result of treadmill
training.
Several mechanisms have been proposed to explain the
improvement in gait induced by treadmill training in PD. For
example, the treadmill may provide propioceptive signals,
triggering intact circuits and bypassing the defective pallidocor-
tical circuit [13] and increasing corticomotor excitability to
induce motor learning [21]. However, it remains unknown how
these mechanisms can then lead to enhanced gait overground
since in our study the patients did not improve their stride length
on the treadmill. In addition, one limitation of this study is the
small number of participants. Nevertheless, this study clearly
shows, for ﬁrst time, that the effects associated with treadmill
training are related with the treadmill itself and not due to the
amount of walking since no effects were found in the overground
group.
The treadmill training program used in this study was
characterized by a very low intensity and a constant speed that
was maintained across sessions. This may explain the fact that the
average increase in stride length was only 5.7%, slightly inferior to a
previously study using high intensity and incremental speed
treadmill training [12]. Thus, it seems that high intensity treadmill
training or incremental speed is not necessarily required in order
to achieve a signiﬁcant improvement in gait, which can make the
use of treadmill training more accessible even to advanced PD
patients with physical ﬁtness disabilities.
The present study provides evidence of a speciﬁc therapeutic
effect of treadmill training on Parkinsonian gait and balance. This is
of relevance since treadmill training can be used as an easy,
effective and accessible way to improve the stride length and
balance in PD patients.
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